Results 221 to 230 of about 436,571 (380)

INHIBITION OF ANTI-HLA-B7 ALLOREACTIVE CTL BY AFFINITY-PURIFIED SOLUBLE HLA

, 1991
Nicholaus Zavazava, Rudolf Hausmann, W Müller-Ruchholtz   +2 more
openalex   +1 more source

Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specificMAGE-2 gene product [PDF]

, 1997
Marjan J.W. Visseren, Sjoerd H. van der Burg, Ellen I. H. van der Voort, Remco M.P. Brandt, Peter I. Schrier, Pierre van der Bruggen, Thierry Boon, Cornelis J.M. Melief, W. Martin Kast   +8 more
openalex   +1 more source

Mechanotransduction in Shaping Immunity: Pathways, Crosstalk, and Pathophysiological Relevance

Advanced Science, EarlyView.
This review comprehensively summarizes the role of mechanotransduction in shaping immunity. It details how immune cells respond to biomechanical cues via mechanotransduction cascades and emphasizes the mechanical crosstalks within the immune microenvironment. The emerging significance of mechanoimmunology in both health and diseases is also highlighted.
Ruijiao Yan, Yuyu Li, Shuo Chen, Li Zhu, Chenchen Zhou, Jianwei Chen, Shujuan Zou, Xianglong Han   +7 more
wiley   +1 more source

Irradiation of Tumor Cells Up-Regulates Fas and Enhances CTL Lytic Activity and CTL Adoptive Immunotherapy

Journal of Immunology, 2003
M. Chakraborty, S. Abrams, K. Camphausen, Kebin Liu, T. Scott, C. N. Coleman, J. Hodge   +6 more
semanticscholar   +1 more source

Engineering Osteoimmune Responses with Functionalized Orthopedic Implants for Post‐Operative Osteosarcoma Treatment

Advanced Science, EarlyView.
Osteosarcoma is the most common primary bone tumor with limited treatment options and a terrible prognosis. This review provides a comprehensive summary of the recent development of osteoimmunomodulatory implants for post‐operative osteosarcoma treatment, of which the potential utility in evoking durable anti‐osteosarcoma immunity and accelerating bone
Yilong Dong, Lingshuang Wang, Hui Zhang, Menghuan Li, Zhong Luo, Yan Hu, Chunyuan Cai   +6 more
wiley   +1 more source

Antibody for tumor related mucin and CTL.

, 1993
高橋 徹, 牧口 祐介, 日野田 裕治, 今井 浩三   +3 more
openalex   +2 more sources

Anti‐L‐selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area [PDF]

, 1996
Antonio Rosato, Annalisa Zambon, Beatrice Macino, Susanna Mandruzzato, Vincenzo Bronte, Gabriella Milan, Paola Zanovello, Dino Collavo   +7 more
openalex   +1 more source

Reversion of CTL escape–variant immunodeficiency viruses in vivo

Nature Network Boston, 2004
T. Friedrich, E. Dodds, Levi J. Yant, L. Vojnov, R. Rudersdorf, Candice Cullen, David T. Evans, R. Desrosiers, B. Mothé, J. Sidney, A. Sette, K. Kunstman, Steven Wolinsky, M. Piatak, J. Lifson, A. Hughes, N. Wilson, D. O’Connor, D. Watkins   +18 more
semanticscholar   +1 more source

Decoding Buried Interfaces in Perovskite Solar Cells: Core Issues, Strategic Engineering, and Prospects for High‐Efficiency Stable Devices

Advanced Science, EarlyView.
This review offers a thorough overview of the diverse buried interfaces in PSCs, emphasizing the associated issues, such as defects, perovskite terminations, strain, carrier dynamics, and chemical reactions. Moreover, the buried interface issues in both the widely studied SAM‐based devices and perovskite/silicon tandem solar cells are discussed in ...
Peng Mao, Weihui Bi, Jun Lv, Zongbao Zhang, Bing Wang, Yufei Zhong   +5 more
wiley   +1 more source

Induction and analysis of CTL for autochthonous tumor.

, 1991
佐藤 昇志, 菊地 浩吉
openalex   +2 more sources